Adapting to sightedness after a lifetime of blindness can be as difficult as the opposite. These cases teach us much about ...

Financial systems that rely on temporal precision may find AI’s unpredictability intolerable. The economic promise of AI automation has already suffered from such blind spots. PwC has noted that many ...

The FDA has approved upadacitinib, a Janus kinase inhibitor, for the treatment of giant cell arteritis in adults-marking the first new approval for the condition since tocilizumab in ...

This enhancement also extends to their auditory temporal resolution abilities. Several studies have demonstrated that early-blind individuals show advantages in temporal-order judgment ability (Weaver ...

Recently, I came across the term “time blindness,” and it was a real eye-opener. It’s a concept that describes the difficulty some people have with perceiving and managing time -- often ...

SELECT-GCA (M16-852) is a phase 3, multicenter, randomized, double-blind placebo-controlled study designed ... sustained remission in the first period. Giant cell arteritis (GCA), also known as ...

The US Food and Drug Administration (FDA) has granted approval for AbbVie’s 15mg Rinvoq (upadacitinib) to treat adults with giant cell arteritis (GCA). The approval follows the recent marketing ...

We report for the first time a case of Erdheim-Chester disease with histologic evidence of temporal artery inflammation in a patient who had symptoms of giant cell arteritis. 2. Case Report Evaluation ...

Also known as temporal arteritis, giant cell arteritis (GCA) is inflammation of the lining of the arteries that run along the temple. GCA usually creates a headache that causes constant, throbbing ...

GCA, also known as temporal arteritis, is the most prevalent form of vasculitis in Western countries, affecting adults’ cranial arteries and potentially leading to serious health complications, ...